These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
502 related items for PubMed ID: 19383521
21. Nonviral in vivo delivery of therapeutic small interfering RNAs. Aigner A. Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447 [Abstract] [Full Text] [Related]
22. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Choi YS, Lee JY, Suh JS, Kwon YM, Lee SJ, Chung JK, Lee DS, Yang VC, Chung CP, Park YJ. Biomaterials; 2010 Feb; 31(6):1429-43. PubMed ID: 19954842 [Abstract] [Full Text] [Related]
23. The use of cell-penetrating peptides as a tool for gene regulation. Järver P, Langel U. Drug Discov Today; 2004 May 01; 9(9):395-402. PubMed ID: 15081956 [Abstract] [Full Text] [Related]
24. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA. Liu B. Brief Funct Genomic Proteomic; 2007 Jun 01; 6(2):112-9. PubMed ID: 17670766 [Abstract] [Full Text] [Related]
25. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Takahashi Y, Nishikawa M, Takakura Y. Adv Drug Deliv Rev; 2009 Jul 25; 61(9):760-6. PubMed ID: 19386274 [Abstract] [Full Text] [Related]
26. Enhancing endosomal escape for nanoparticle mediated siRNA delivery. Ma D. Nanoscale; 2014 Jun 21; 6(12):6415-25. PubMed ID: 24837409 [Abstract] [Full Text] [Related]
27. Polycation gene delivery systems: escape from endosomes to cytosol. Cho YW, Kim JD, Park K. J Pharm Pharmacol; 2003 Jun 21; 55(6):721-34. PubMed ID: 12841931 [Abstract] [Full Text] [Related]
28. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery. Wang XL, Ramusovic S, Nguyen T, Lu ZR. Bioconjug Chem; 2007 Jun 21; 18(6):2169-77. PubMed ID: 17939730 [Abstract] [Full Text] [Related]
29. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs. Kim EJ, Shim G, Kim K, Kwon IC, Oh YK, Shim CK. J Gene Med; 2009 Sep 21; 11(9):791-803. PubMed ID: 19569085 [Abstract] [Full Text] [Related]
30. Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery. Wang M, Li X, Ma Y, Gu H. Int J Pharm; 2013 May 01; 448(1):51-7. PubMed ID: 23524121 [Abstract] [Full Text] [Related]
31. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Xiong XB, Uludağ H, Lavasanifar A. Biomaterials; 2009 Jan 01; 30(2):242-53. PubMed ID: 18838158 [Abstract] [Full Text] [Related]
32. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Bartz R, Fan H, Zhang J, Innocent N, Cherrin C, Beck SC, Pei Y, Momose A, Jadhav V, Tellers DM, Meng F, Crocker LS, Sepp-Lorenzino L, Barnett SF. Biochem J; 2011 Apr 15; 435(2):475-87. PubMed ID: 21265735 [Abstract] [Full Text] [Related]
34. Barriers to successful delivery of short interfering RNA after systemic administration. White PJ. Clin Exp Pharmacol Physiol; 2008 Nov 15; 35(11):1371-6. PubMed ID: 18565190 [Abstract] [Full Text] [Related]
35. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Deshayes S, Morris M, Heitz F, Divita G. Adv Drug Deliv Rev; 2008 Mar 01; 60(4-5):537-47. PubMed ID: 18037526 [Abstract] [Full Text] [Related]
36. PTD-DRBD siRNA delivery. Palm-Apergi C, Eguchi A, Dowdy SF. Methods Mol Biol; 2011 Mar 01; 683():339-47. PubMed ID: 21053141 [Abstract] [Full Text] [Related]
39. Functionalization of carbon nanotubes enables non-covalent binding and intracellular delivery of small interfering RNA for efficient knock-down of genes. Krajcik R, Jung A, Hirsch A, Neuhuber W, Zolk O. Biochem Biophys Res Commun; 2008 May 02; 369(2):595-602. PubMed ID: 18298946 [Abstract] [Full Text] [Related]
40. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics. Akhtar S. Expert Opin Drug Metab Toxicol; 2010 Nov 02; 6(11):1347-62. PubMed ID: 20929276 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]